Availability of enabling technologies for the large-scale purification of recombinant proteins is an essential requirement of the biotechnology industry. This project aims to integrate two concepts in molecular biorecognition. New modalities of immobilised metal ion affinity chromatography will be linked with the selection of new types of peptide affinity handles that can be inserted by genetic engineering methods into proteins produced by biotechnological procedures. The approach followed then allows these handles to be removed following isolation of the target protein. This project could thus lead to a considerable advance in the manufacture of recombinant proteins intended for human therapy.
|Effective start/end date||30/03/05 → 31/12/08|
- Australian Research Council (ARC): AUD1,160,021.00
- Novo Nordisk Pharmaceuticals Pty Ltd: AUD928,200.00
- Monash University